Browsing Tag
EQT
29 posts
From cargo surveys to £10.9bn takeover: How Intertek became EQT’s prized target
Intertek Group has spent more than a century turning scientific testing, inspection and certification into a global trust network. EQT’s takeover shows why that network may be more valuable in private hands than London investors recognised.
Intertek agrees £10.9bn EQT takeover as board recommends final £60 cash offer
Intertek agrees EQT’s £10.9bn takeover. See what the £60 cash offer, dividend, shareholder vote and London delisting mean for ITRK investors and employees.
Intertek (ITRK) board set to back £60-a-share EQT takeover as ITRK approaches London exit
Intertek is set to back EQT’s £60-a-share offer. See what the £10.6bn deal means for ITRK holders, UK markets and ATIC growth.
Can Caturus turn Commonwealth LNG into America’s next integrated gas export powerhouse?
Caturus clears Commonwealth LNG FID with $9.75B financing. Find out how the Louisiana project could reshape U.S. gas exports.
Intertek board opens door to EQT’s £60-a-share takeover bid as ITRK trades near 52-week high
Intertek says its strategy can create value. EQT is offering cash now. The £60-a-share bid turns patience into a boardroom test.
Scout24 (ETR: G24) stock pops as ImmoScout24 owner unveils Agentic OS and lifts targets
Online classifieds are supposed to be losing to AI. Scout24 just turned that thesis around with immo.ai, an Agentic OS, and a 64% margin target by 2028.
Scout24 SE (ETR: G24): Can a DAX upgrade and Spain expansion re-rate a quality stock near 52-week lows?
Scout24 SE (ETR: G24) has fallen over 45% from its 2025 high. With a EUR 500M buyback, 16-18% revenue growth guidance and a consensus target near EUR 110, here is what retail investors need to know before Q1 results on April 29.
Acumatica 2026 R1 brings AI-driven project risk tools to construction ERP as margin pressure intensifies
Acumatica 2026 R1 brings AI anomaly detection, cost forecasting, and billing automation to its Construction Edition. Read the full analysis on BNT.
Galderma share buyback: CHF 232m repurchase follows full exit by EQT, ADIA, and Auba Investment
Galderma repurchases CHF 232M in shares as EQT exits. Discover what the buyback and ownership shift mean for the dermatology company and investors.
EQT is out. What its €190m Azelis exit says about private equity timing in specialty chemicals
EQT has exited Azelis Group NV with a €190 million selldown. Find out what this means for investors, valuation, and the specialty chemicals sector.